CG
CBIO

Cutler Group’s Crescent Biopharma CBIO Stock Holding History

Cutler Group’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Hold
0
– – – 4373
2019
Q4 		– Sell
-10
Closed -$5.41K – 4351
2019
Q3 		$4K Buy
+10
New +$6.43K ﹤0.01% 3156
2019
Q2 		– Sell
-1
Closed -$1.2K – 4604
2019
Q1 		$1K Buy
+1
New +$1.15K ﹤0.01% 3673
2018
Q4 		– Sell
-30
Closed -$43K – 4289
2018
Q3 		$43K Sell
30
-13
-30% -$19.7K ﹤0.01% 1698
2018
Q2 		$69K Buy
43
+29
+207% +$49.9K 0.01% 1396
2018
Q1 		$23K Buy
14
+10
+250% +$20.8K ﹤0.01% 2180
2017
Q4 		$6K Buy
4
+1
+33% +$1.32K ﹤0.01% 3482
2017
Q3 		$4K Sell
3
-4
-57% -$4.7K ﹤0.01% 4563
2017
Q2 		$7K Buy
+7
New +$5.78K ﹤0.01% 4515

Other funds holding CBIO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $718M AUM 8.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return